Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne C. Drevets

Showing results (71-80 of 264) with videos related to

Pageof 27
Sort By:
The International Journal of Neuropsychopharmacology|December 16, 2022
Adverse Events and Measurement of Dissociation After the First Dose of Esketamine in Patients With TRDDavid Williamson, Ibrahim Turkoz, Ewa Wajs, et al.
Brain, Behavior, and Immunity|April 20, 2016
Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depressionKymberly D Young, Wayne C Drevets, Robert Dantzer, et al.
CNS Drugs|April 20, 2022
Evaluation of Individual Items of the Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) in Adults with Treatment-Resistant Depression Treated with Esketamine Nasal Spray Combined with a New Oral AntidepressantLysbeth Floden, Stacie Hudgens, Carol Jamieson, et al.
Neuroimage|August 23, 2008
Serotonin transporter genotype and depressive phenotype determination by discriminant analysis of glucose metabolism under acute tryptophan depletionAllison C Nugent, Alexander Neumeister, David Goldman, et al.
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 24, 2006
Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targetsPaul J Carlson, Jaskaran B Singh, Carlos A Zarate, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|March 19, 2011
Sex differences in the neural correlates of autonomic arousal: a pilot PET studyAllison C Nugent, Earle E Bain, Julian F Thayer, et al.
The International Journal of Neuropsychopharmacology|March 31, 2015
Pretreatment Differences in BOLD Response to Emotional Faces Correlate with Antidepressant Response to ScopolamineMaura L Furey, Wayne C Drevets, Joanna Szczepanik, et al.
Journal of Affective Disorders|May 21, 2021
Exploring real-world evidence to uncover unknown drug benefits and support the discovery of new treatment targets for depressive and bipolar disordersRachel E Teneralli, David M Kern, M Soledad Cepeda, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 8, 2007
Cerebral blood flow in immediate and sustained anxietyGregor Hasler, Stephen Fromm, Ruben P Alvarez, et al.
Journal of Neuroimmunology|March 16, 2010
High levels of Anti-GAD65 and Anti-Ro52 autoantibodies in a patient with major depressive disorder showing psychomotor disturbanceKathryn H Ching, Peter D Burbelo, Paul J Carlson, et al.
Pageof 27

Showing results (71-80 of 264) with videos related to

Sort By:
Pageof 27
The International Journal of Neuropsychopharmacology|December 16, 2022
Adverse Events and Measurement of Dissociation After the First Dose of Esketamine in Patients With TRDDavid Williamson, Ibrahim Turkoz, Ewa Wajs, et al.
Brain, Behavior, and Immunity|April 20, 2016
Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depressionKymberly D Young, Wayne C Drevets, Robert Dantzer, et al.
CNS Drugs|April 20, 2022
Evaluation of Individual Items of the Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) in Adults with Treatment-Resistant Depression Treated with Esketamine Nasal Spray Combined with a New Oral AntidepressantLysbeth Floden, Stacie Hudgens, Carol Jamieson, et al.
Neuroimage|August 23, 2008
Serotonin transporter genotype and depressive phenotype determination by discriminant analysis of glucose metabolism under acute tryptophan depletionAllison C Nugent, Alexander Neumeister, David Goldman, et al.
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 24, 2006
Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targetsPaul J Carlson, Jaskaran B Singh, Carlos A Zarate, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|March 19, 2011
Sex differences in the neural correlates of autonomic arousal: a pilot PET studyAllison C Nugent, Earle E Bain, Julian F Thayer, et al.
The International Journal of Neuropsychopharmacology|March 31, 2015
Pretreatment Differences in BOLD Response to Emotional Faces Correlate with Antidepressant Response to ScopolamineMaura L Furey, Wayne C Drevets, Joanna Szczepanik, et al.
Journal of Affective Disorders|May 21, 2021
Exploring real-world evidence to uncover unknown drug benefits and support the discovery of new treatment targets for depressive and bipolar disordersRachel E Teneralli, David M Kern, M Soledad Cepeda, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 8, 2007
Cerebral blood flow in immediate and sustained anxietyGregor Hasler, Stephen Fromm, Ruben P Alvarez, et al.
Journal of Neuroimmunology|March 16, 2010
High levels of Anti-GAD65 and Anti-Ro52 autoantibodies in a patient with major depressive disorder showing psychomotor disturbanceKathryn H Ching, Peter D Burbelo, Paul J Carlson, et al.
Pageof 27